In-human clinical experience with direct stick embolization of low-flow vascular malformations using a mammalian target of rapamycin inhibitor
Our findings suggest that DSE of LFVMs with mTOR inhibitors (Yale-OCR7737) may be safe and effective. This may represent the new embolotherapeutic frontier in the endovascular treatment of LFMVs.
Authors
- Naiem Nassiri (ORCID: https://orcid.org/0000-0002-1479-4708)
- Stephanie Prozora (ORCID: https://orcid.org/0000-0002-5022-8885)
- Alfred Ian Lee (ORCID: https://orcid.org/0000-0002-5968-3948)
- Prashant Patel (ORCID: https://orcid.org/0000-0002-1708-0292)
- Valentina Restrepo-Espinosa (ORCID: https://orcid.org/0000-0002-3330-8373)
Institutions
- Yale New Haven Hospital (US)
- Yale University (US)
- Yale New Haven Health System (US)
Publication Details
- Journal
- Journal of Vascular Surgery Venous and Lymphatic Disorders
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1016/j.jvsv.2024.101997
- Citations
- 1
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.57